Harbinger Health | BiotechTV

top of page

Harbinger Health is announcing its emphasis on a new category of cancer screening tests today, RESOLVE, that are meant to be used upon the suspicion of cancer symptoms to speed diagnosis and treatment

CEO Ajit Singh describes the idea behind the new products, and highlights that $100M has been raised to fund the development of them.

Company News

7 days ago

Harbinger Health’s Steve Hahn on the science of early cancer Dx after raising a $140M Series B

Steve Hahn describes how Harbinger Health is trying to catch the earliest signals of cancer, and how this information might be used.

Company News

Sep 28, 2023

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

HSBC Innovation Banking's dedicated sector experts possess in-depth knowledge of the technology, life science and healthcare economies. With access to an extensive global network, we can help you fuel growth through venture capital and corporate investors, industry influencers, customers, and global opportunities.

Through our interconnected innovation hubs in the US, UK, Israel and Hong Kong, our experts are supporting the world’s innovation economy – both clients and their investors to help them meet their growth goals.

Learn more

bottom of page

Harbinger Health is announcing its emphasis on a new category of cancer screening tests today, RESOLVE, that are meant to be used upon the suspicion of cancer symptoms to speed diagnosis and treatment

Harbinger Health’s Steve Hahn on the science of early cancer Dx after raising a $140M Series B

Follow BiotechTV

Sponsors

Sponsor Spotlight